Literature DB >> 25985272

Kidney growth and hypertrophy: the role of mTOR and vesicle trafficking.

Qais Al-Awqati.   

Abstract

The kidney, like other organs, grows in constant proportion to the rest of the body. When one kidney is removed, the remaining one hypertrophies. In a comprehensive series of studies, Chen et al. show that growth during maturation is mediated by the mTORC1 signaling pathway, which is induced by EGF-like peptides, and requires PI3K, PDK, AKT, mTORC2, and activation of mTORC1 through the combined effects of TSC and RHEB as part of a multiprotein complex localized on lysosomes. However, compensatory growth is mediated by amino acids, which act on mTORC1 independently of the previous pathway, and requires a class III PI3K (VPS34) that is known to be involved in vesicle trafficking to the lysosomes.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25985272      PMCID: PMC4497766          DOI: 10.1172/JCI81508

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  14 in total

Review 1.  Mannose 6-phosphate receptors: new twists in the tale.

Authors:  Pradipta Ghosh; Nancy M Dahms; Stuart Kornfeld
Journal:  Nat Rev Mol Cell Biol       Date:  2003-03       Impact factor: 94.444

2.  Independence of onset of compensatory kidney growth from changes in renal function.

Authors:  A I Katz; F G Toback; M D Lindheimer
Journal:  Am J Physiol       Date:  1976-04

3.  A highly potent and selective Vps34 inhibitor alters vesicle trafficking and autophagy.

Authors:  Baptiste Ronan; Odile Flamand; Lionel Vescovi; Christine Dureuil; Laurence Durand; Florence Fassy; Marie-France Bachelot; Annabelle Lamberton; Magali Mathieu; Thomas Bertrand; Jean-Pierre Marquette; Youssef El-Ahmad; Bruno Filoche-Romme; Laurent Schio; Carlos Garcia-Echeverria; Hélène Goulaouic; Benoit Pasquier
Journal:  Nat Chem Biol       Date:  2014-10-19       Impact factor: 15.040

4.  Metabolism. Lysosomal amino acid transporter SLC38A9 signals arginine sufficiency to mTORC1.

Authors:  Shuyu Wang; Zhi-Yang Tsun; Rachel L Wolfson; Kuang Shen; Gregory A Wyant; Molly E Plovanich; Elizabeth D Yuan; Tony D Jones; Lynne Chantranupong; William Comb; Tim Wang; Liron Bar-Peled; Roberto Zoncu; Christoph Straub; Choah Kim; Jiwon Park; Bernardo L Sabatini; David M Sabatini
Journal:  Science       Date:  2015-01-07       Impact factor: 47.728

5.  Rab1A is an mTORC1 activator and a colorectal oncogene.

Authors:  Janice D Thomas; Yan-Jie Zhang; Yue-Hua Wei; Jun-Hung Cho; Laura E Morris; Hui-Yun Wang; X F Steven Zheng
Journal:  Cancer Cell       Date:  2014-10-23       Impact factor: 31.743

6.  Phosphatidylinositol 3-kinase signaling determines kidney size.

Authors:  Jian-Kang Chen; Kojiro Nagai; Jianchun Chen; David Plieth; Masayo Hino; Jinxian Xu; Feng Sha; T Alp Ikizler; C Chad Quarles; David W Threadgill; Eric G Neilson; Raymond C Harris
Journal:  J Clin Invest       Date:  2015-05-18       Impact factor: 14.808

7.  FKBP12-rapamycin-associated protein or mammalian target of rapamycin (FRAP/mTOR) localization in the endoplasmic reticulum and the Golgi apparatus.

Authors:  Ryan M Drenan; Xiangyu Liu; Paula G Bertram; X F Steven Zheng
Journal:  J Biol Chem       Date:  2003-10-24       Impact factor: 5.157

8.  Relation of glomerular filtration rate and sodium reabsorption to kidney size in compensatory renal hypertrophy.

Authors:  A I Katz; F H Epstein
Journal:  Yale J Biol Med       Date:  1967-12

9.  SLC38A9 is a component of the lysosomal amino acid sensing machinery that controls mTORC1.

Authors:  Manuele Rebsamen; Lorena Pochini; Taras Stasyk; Mariana E G de Araújo; Michele Galluccio; Richard K Kandasamy; Berend Snijder; Astrid Fauster; Elena L Rudashevskaya; Manuela Bruckner; Stefania Scorzoni; Przemyslaw A Filipek; Kilian V M Huber; Johannes W Bigenzahn; Leonhard X Heinz; Claudine Kraft; Keiryn L Bennett; Cesare Indiveri; Lukas A Huber; Giulio Superti-Furga
Journal:  Nature       Date:  2015-01-07       Impact factor: 49.962

10.  Metabolism. Differential regulation of mTORC1 by leucine and glutamine.

Authors:  Jenna L Jewell; Young Chul Kim; Ryan C Russell; Fa-Xing Yu; Hyun Woo Park; Steven W Plouffe; Vincent S Tagliabracci; Kun-Liang Guan
Journal:  Science       Date:  2015-01-07       Impact factor: 47.728

View more
  2 in total

1.  Lowe syndrome patient cells display mTOR- and RhoGTPase-dependent phenotypes alleviated by rapamycin and statins.

Authors:  Kayalvizhi Madhivanan; Swetha Ramadesikan; Wen-Chieh Hsieh; Mariana C Aguilar; Claudia B Hanna; Robert L Bacallao; R Claudio Aguilar
Journal:  Hum Mol Genet       Date:  2020-06-27       Impact factor: 6.150

2.  Tsc1 ablation in Prx1 and Osterix lineages causes renal cystogenesis in mouse.

Authors:  Zhixiang Wu; Hongguang Wu; Shafiquzzaman Md; Guo Yu; Samy L Habib; Baojie Li; Jing Li
Journal:  Sci Rep       Date:  2019-01-29       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.